MYELODYSPLASTIC SYNDROME AND LEUKEMIA IS A SECONDARY EVENT AFTER BONE MARROW FAILURE IN GATA2 HAPLOINSUFFICIENT MICE

• Cansu Koyunlar,
• Juncal Fernandez-Orth,
• Julia Weiss,
• Emanuele Gioacchino,
• HansDe Looper,
• Geoffrey Andrieux,
• Mariette Ter Borg,
• Baris Yigit,
• Joke Zink,
• Remco Hoogenboezem,
• Irene Gonzalez-Mendez,
• Eric Bindels,
• Mathijs Sanders,
• Ivo Touw,
• Miriam Erlacher,
• Emma De Pater

Affiliations

Cansu Koyunlar

Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands;

Juncal Fernandez-Orth

Division of Pediatric of Hematology and Oncology, University Medical Center Freiburg, Freiburg, Germany;

Julia Weiss

Division of Pediatric of Hematology and Oncology, University Medical Center Freiburg, Freiburg, Germany;

Emanuele Gioacchino

Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands;

HansDe Looper

Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands;

Geoffrey Andrieux

Institute of Medical Bioinformatics and Systems Medicine, Albert-Ludwigs-Universität Freiburg, Germany;

Mariette Ter Borg

Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands;

Baris Yigit

Division of Pediatric of Hematology and Oncology, University Medical Center Freiburg, Freiburg, Germany;

Joke Zink

Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands;

Remco Hoogenboezem

Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands;

Irene Gonzalez-Mendez

Institute of Pathology and Neuropathology University of Tuebingen, Tuebingen, Germany

Eric Bindels

Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands;

Mathijs Sanders

Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands;

Ivo Touw

Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands;

Miriam Erlacher

Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands;

Emma De Pater

dept of Hematology, Erasmus MC Cancer Center, Rotterdam, The Netherlands;